Causes of death among people who used illicit opioids in England, 2001–18: a matched cohort study

Abstract

Background In many countries, the average age of people who use illicit opioids, such as heroin, is increasing. This has been suggested to be a reason for increasing numbers of opioid-related deaths seen in surveillance data. We aimed to describe causes of death among people who use illicit opioids in England, how causes of death have changed over time, and how they change with age. MethodsIn this matched cohort study, we studied patients in the Clinical Practice Research Datalink with recorded illicit opioid use (defined as aged 18-64 years, with prescriptions or clinical observations that indicate use of illicit opioids) in England between Jan 1, 2001, and Oct 30, 2018. We also included a comparison group, matched (1:3) for age, sex, and general practice with no records of illicit opioid use before cohort entry. Dates and causes of death were obtained from the UK Office for National Statistics. The cohort exit date was the earliest of date of death or Oct 30, 2018. We described rates of death and calculated cause-specific standardised mortality ratios. We used Poisson regression to estimate associations between age, calendar year, and cause-specific death. Findings We collected data for 106 789 participants with a history of illicit opioid use, with a median follow-up of 8•7 years (IQR 4•3-13•5), and 320 367 matched controls with a median follow-up of 9•5 years (5•0-14•4). 13 209 (12•4%) of 106 789 participants in the exposed cohort had died, with a standardised mortality ratio of 7•72 (95% CI 7•47-7•97). The most common causes of death were drug poisoning (4375 [33•1%] of 13 209), liver disease (1272 [9•6%]), chronic obstructive pulmonary disease (COPD; 681 [5•2%]), and suicide (645 [4•9%]). Participants with a history of illicit opioid use had higher mortality rates than the comparison group for all causes of death analysed, with highest standardised mortality ratios being seen for viral hepatitis (103•5 [95% CI 61•7-242•6]), HIV (16•7 [9•5-34•9]), and COPD (14•8 [12•6-17•6]). In the exposed cohort, at age 20 years, the rate of fatal drug poisonings was 271 (95% CI 230-313) per 100 000 person-years, accounting for 59•9% of deaths at this age, whereas the mortality rate due to non-communicable diseases was 31 (16-45) per 100 000 person-years, accounting for 6•8% of deaths at this age. Deaths due to non-communicable diseases increased more rapidly with age (1155 [95% CI 880-1431] deaths per 100 000 person-years at age 50 years; accounting for 52•0% of deaths at this age) than did deaths due to drug poisoning (507 (95% CI 452-562) per 100 000 person-years at age 50 years; accounting for 22•8% of deaths at this age). Mirroring national surveillance data, the rate of fatal drug poisonings in the exposed cohort increased from 345 (95% CI 299-391) deaths per 100 000 person-years in 2010-12 to 534 (468-600) per 100 000 person-years in 2016-18; an increase of 55%, a trend that was not explained by ageing of participants.Interpretation People who use illicit opioids have excess risk of death across all major causes of ...

The characteristics of people who inject drugs in the United Kingdom: changes in age, duration, and incidence of injecting, 1980–2019, using evidence from repeated cross‐sectional surveys

“…Ageing is associated with an increasing importance of long‐term health conditions. As the cohort of the 1980s and 1990s has got older, the main causes of death have shifted from infections and drug overdoses to non‐communicable diseases [32]. The prevalence of long‐term conditions is now very high.…”

Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records

“…Fatal overdose risk during and after treatment provision has been widely studied, 6 and may differ by treatment modality, 7 age, 8 and health status, 9 but little is known about the risk of hospitalisation due to overdose. Although sustained treatment with opioid agonists is associated with reduced non-fatal overdose risk compared to no treatment or non-pharmacological interventions, 10 the potential association between different pharmacotherapies and overdose risk, short- and long-term, is incompletely understood.…”

Mortality in people who use illicit opioids in England

“…This study by Lewer and colleagues 3 makes an important contribution to our understanding of the mortality burden associated with illicit opioid use. It is clear from their findings that a one-size-fits-all response to this public health crisis will not protect this vulnerable population over their life course.…”